AFFiRiS
Phase 1We are a clinical‑stage biotechnology company striving to deliver novel therapies to patients with neurodegenerative diseases
Founded
2003
Focus
Vaccines
About
We are a clinical‑stage biotechnology company striving to deliver novel therapies to patients with neurodegenerative diseases
Funding History
4Total raised: $133M
Grant$8MMichael J. Fox FoundationJun 15, 2018
Series C$60MMIG FundsJun 15, 2015
Series B$40MMIG FundsJun 15, 2011
Series A$25MMIG FundsJun 15, 2007
Company Info
TypePrivate
Founded2003
LocationVienna, Austria
StagePhase 1
Contact
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile